Aurinia Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.3M | 842k | 11.05 |
| 2025-03-31 | $13M | 1.6M | 8.04 |
| 2024-12-31 | $16M | 1.8M | 8.98 |
| 2024-09-30 | $18M | 2.4M | 7.33 |
| 2024-06-30 | $13M | 2.3M | 5.71 |
| 2024-03-31 | $11M | 2.2M | 5.01 |
| 2023-12-31 | $18M | 2.0M | 8.99 |
| 2023-09-30 | $11M | 1.5M | 7.77 |
| 2023-06-30 | $17M | 1.7M | 9.68 |
| 2023-03-31 | $11M | 990k | 10.96 |
| 2022-12-31 | $2.0M | 471k | 4.32 |
| 2022-06-30 | $7.2M | 720k | 10.05 |
| 2022-03-31 | $3.8M | 310k | 12.38 |
| 2021-12-31 | $6.3M | 273k | 22.87 |
| 2021-09-30 | $3.9M | 176k | 22.13 |
| 2021-03-31 | $3.9M | 300k | 12.98 |
| 2020-12-31 | $2.4M | 172k | 13.83 |
| 2020-09-30 | $2.6M | 180k | 14.73 |
| 2020-06-30 | $4.4M | 269k | 16.25 |
| 2019-12-31 | $13M | 623k | 20.26 |
| 2019-09-30 | $8.8M | 1.7M | 5.34 |
| 2019-06-30 | $7.5M | 1.1M | 6.58 |
| 2019-03-31 | $9.0M | 1.4M | 6.50 |
| 2018-12-31 | $11M | 1.7M | 6.83 |
| 2018-09-30 | $12M | 1.7M | 6.64 |
| 2018-06-30 | $10M | 1.8M | 5.63 |
| 2018-03-31 | $6.4M | 1.2M | 5.19 |
| 2017-12-31 | $5.4M | 1.2M | 4.53 |
| 2017-09-30 | $5.5M | 875k | 6.27 |
| 2017-06-30 | $5.4M | 877k | 6.13 |
| 2017-03-31 | $3.7M | 502k | 7.34 |
| 2016-12-31 | $2.7M | 1.3M | 2.10 |
| 2016-09-30 | $1.1M | 375k | 3.01 |
| 2016-03-31 | $61k | 21k | 2.89 |